- Home
- CNTB vs JELD Comparison
CNTB vs JELD Comparison
Compare CNTB & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTB | JELD |
|---|---|---|
| Founded | 2012 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 152.5M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CNTB | JELD |
|---|---|---|
| Price | $1.97 | $1.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $8.67 | $3.43 |
| AVG Volume (30 Days) | 302.6K | ★ 1.5M |
| Earning Date | 08-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $64,000.00 | ★ $3,211,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $0.93 |
| 52 Week High | $3.82 | $6.98 |
Technical Indicators
Market Signals| Indicator | CNTB | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 46.73 |
| Support Level | $1.46 | $1.64 |
| Resistance Level | $2.05 | $2.15 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 11.71 | 14.55 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.